Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Strategy and Product Portfolio
BMRN logo

BioMarin Revenue Surges 18% to $2.9B on VOXZOGO Boom

BMRN10-KFiling Date: 2/24/2025
BioMarin Pharmaceutical Inc.
Description

What this story covers

BioMarin reported $2.9B revenue in 2024, up 18%, led by VOXZOGO's 57% growth to $735M. Strong liquidity at $1.7B supports pipeline expansions amid regulatory and competitive risks. Net income rose 155% to $427M, signaling profitability shift.

Story snapshot

CompanyBioMarin Pharmaceutical Inc.
TickerBMRN
VariantStandard detailed
Duration13:46
Filing type10-K
PeriodAnnual 2024
IndustryHealthcare & Pharmaceuticals
Accession0001048477-25-000007

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in